Statistical considerations for performing multiple tests in a single experiment. 5. Comparing two therapies with respect to several endpoints.
about
Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitors.A long-term study of policosanol in the treatment of intermittent claudication.Investigating the effect of intra-operative infiltration with local anaesthesia on the development of chronic postoperative pain after inguinal hernia repair. A randomized placebo controlled triple blinded and group sequential study design [NCT00484Mindfulness meditation training to reduce symptom distress in transplant patients: rationale, design, and experience with a recycled waitlistResearch fundamentals: statistical considerations in research design: a simple person's approach.Effects of D-003 (10 mg/day) on bone mineral density of the lumbar spine and femoral neck in postmenopausal women: a randomized, double-blinded study.Effects of policosanol treatment on the susceptibility of low density lipoprotein (LDL) isolated from healthy volunteers to oxidative modification in vitro.Clinical trials. A guide to understanding methodology and interpreting results.Controlled release of vascular endothelial growth factor using poly-lactic-co-glycolic acid microspheres: in vitro characterization and application in polycaprolactone fumarate nerve conduits.Relative responsiveness of physician/assessor-derived and patient-derived core set measures in rheumatoid arthritis trials.Circulating endothelin in acute ischaemic syndromes.Antiplatelet effects of policosanol (20 and 40 mg/day) in healthy volunteers and dyslipidaemic patients.Neurotoxicological evaluation of hospital sterilizer workers exposed to ethylene oxide.Effects of NK1 receptors on gastric motor functions and satiation in healthy humans: results from a controlled trial with the NK1 antagonist aprepitant.
P2860
Q31038425-F2C23B35-7BF7-4621-8DDD-F8092ADD739BQ32066876-DE1B9D2D-1749-45AF-AAF6-06F709CBD319Q33305134-0355020A-E223-4402-8B2C-7606BC385D36Q33639365-57602CFD-5F49-4CFD-AE2F-652410E0B1C0Q33848223-BDDF4139-E88D-43CA-B5C7-14403010BED2Q35033570-D7133D89-D93E-47F0-92F0-93CFF230731CQ36055271-2D94DA17-6268-4156-B94C-81C13BC0CC34Q38140866-1276505A-BDED-4B71-AFD0-62D33E0572C0Q38590032-13901AB4-FE48-40D3-8E2A-137D23541793Q42562298-3A6B3F46-40B5-448A-B5AD-77A5224689B7Q42577631-A98A5BBA-38C6-449B-AEA9-5F0CBB6D6ED0Q44122688-47007987-EB24-4CCB-B604-C90E557ADD9DQ45985052-07D66FFD-A498-4A6C-AC4F-6B2326769DA8Q47944822-C4880054-AEEA-4B79-A138-71634E66349F
P2860
Statistical considerations for performing multiple tests in a single experiment. 5. Comparing two therapies with respect to several endpoints.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh-hant
name
Statistical considerations for ...... respect to several endpoints.
@en
Statistical considerations for ...... respect to several endpoints.
@nl
type
label
Statistical considerations for ...... respect to several endpoints.
@en
Statistical considerations for ...... respect to several endpoints.
@nl
prefLabel
Statistical considerations for ...... respect to several endpoints.
@en
Statistical considerations for ...... respect to several endpoints.
@nl
P1476
Statistical considerations for ...... respect to several endpoints.
@en
P2093
P C O'Brien
P304
P356
10.1016/S0025-6196(12)65511-6
P407
P577
1988-11-01T00:00:00Z